Latest Industry Insights
Industry Insight
Tandem Mass Spectrometry: Rising to Challenges in Clinical Labs
Assay sensitivity and specificity continues to be a challenge in measuring hormones at low concentrations. Tandem mass spectrometry offers significant advantages - particularly in a clinical setting, where speed and sensitivity are required. Following SCIEX' launch of a new tandem mass spectrometry system, we spoke with Michael Jarvis, Product Manager at SCIEX, to find out more.
Industry Insight
Combating Neurodegenerative and Age-related Diseases
We recently spoke to Karoly Nikolich, chairman and chief executive officer of Alkahest, a clinical-stage biotechnology company, to learn more about their approach to developing therapeutics for both neurodegenerative and age-related diseases.
Industry Insight
Assembling the Pieces of the Genomic Puzzle
OmniTier Inc.’s new bioinformatics platform, CompStorTM Novos, takes a de novo assembly-based variant calling approach to the challenge of whole genome sequencing. We caught up with Jon Coker, Omnitier’s CTO, to discuss how this approach matches up to rival techniques, and how high-performance computing approaches like Omnitier’s hope to bring personalized medicine a step closer and boost biology in coming years.
Industry Insight
Immunotherapy Response Prediction in Urothelial Cancer
While immunotherapy holds great promise for cancer treatment, challenges persist around limited response rate and severe immune-related adverse events. We caught up with Dr. Georg Lautscham, CEO of Protagen, to find out how the prediction of immunotherapy response can be improved for people with urothelial cancer.
Industry Insight
What’s New in the Food Analysis Toolkit?
In areas such as food analysis, where detection of contaminants may be imperative to prevent dangers to consumers, speed and reliability is key. We spoke to Tim Jenkins from Waters Corporation, about their coupling of DART to the QDa mass detector with a software solution aimed to enhance compound identification.
Industry Insight
How to Buy Neuroscience Equipment
Lab equipment purchases, both big and small, require plenty of thought and can have a big impact on the quality of your science. In this blog, MCI Neuroscience's Adam Tozer highlights some tips to making the best purchases.
Industry Insight
How AI Can Speed Up High Content Screening Analysis
High content screeening (HCS) has become a staple tool for scientists trying to find out how molecules alter our cells' biological systems. The huge volume of data that HCS produces is both its strength and weakness. As assays become more complex, companies like Genedata are turning to AI-based approaches to help streamline HCS analysis. I spoke to Genedata's Head of Science, Dr. Stephan Steigele, to find out more.
Industry Insight
Accelerating the Development of Liver Gene Medicines
Recent technology advancements have enabled the opportunity to increase the efficiency, efficacy and safety of gene and cell-based medicines for a multitude of genetic disorders. To date, a major challenge facing the field has been the ability to deliver therapeutic genes to affected cell types. In this blog, Sarah Haecker Meeks and Michael Roberts from Synpromics outline the ways in which gene medicines can be optimized to overcome this barrier.
Industry Insight
The Changing Shape of Optofluidics R&D
Life science businesses are facing growing demand to keep pace in an era of fast-evolving technology. By recognizing the potential challenges, a growing number of companies are leveraging the resources and creativity of their suppliers. We took a look at the landscape of optofluidics R&D.
Industry Insight
Developing Therapies to Fight Cancer and Autoimmune Diseases
We recently spoke to Alexis Peyroles, CEO at OSE Immunotherapeutics to hear more about the findings of their recent study, describing, for the first time ever, the in vivo MOA of interleukin 7 receptor alpha (IL-7Rα) monoclonal antibodies, suggesting therapeutic efficacy in controlling chronic inflammation.
Advertisement